Target intelligence / Profile preview

AGE precursor molecules

Molecular classification
Other (precursor molecules, not protein/enzyme/receptor families)
01

Overview

AGE precursor molecules are chemically reactive species—including reducing sugars (glucose, fructose) and dicarbonyl compounds (such as methylglyoxal and glyoxal)—that initiate the non-enzymatic glycation of proteins, lipids, and nucleic acids in living organisms. These molecules react via the Maillard reaction to form unstable intermediates (Schiff bases and Amadori products), eventually leading to the irreversible formation of Advanced Glycation End Products (AGEs). AGE precursors play a critical role in metabolic and age-related diseases by driving the accumulation of AGEs, which are implicated in tissue cross-linking, inflammation, and cellular dysfunction. However, the molecules themselves are not directly considered therapeutic targets; rather, prevention of their accumulation or promotion of their detoxification (via enzymes or small molecule scavengers) is a focal point of pharmacological research.

Other names
Reducing sugarsGlycation precursorsReactive carbonyl speciesDicarbonyl compounds (e.g., methylglyoxal, glyoxal)
02

Mechanism of action

Small-molecule scavenging or trapping of precursor reactive carbonyls (e.g., aminoguanidine binds methylglyoxal) Enzymatic detoxification (e.g., glyoxalase pathway) Limiting precursor availability through dietary or metabolic interventions

03

Biological functions

Serve as substrates for nonenzymatic glycation reactionsInitiate AGE formation through Maillard reactionContribute to molecular cross-linking and tissue damage via downstream AGE formation
04

Disease associations

Indirectly involved in diabetes and its complications (by driving AGE formation)Cardiovascular diseaseNeurodegenerative disease (e.g., Alzheimer’s, Parkinson’s, due to downstream AGE action)Chronic kidney diseaseAge-related conditions
05

Safety considerations

Therapeutic strategies must avoid trapping beneficial metabolitesRisk of off-target effects with non-specific scavengersPotential for unintended inhibition of normal physiological glycation processes
06

Interacting drugs

Aminoguanidine (suppresses AGE formation by trapping glycation precursors)

3 more in the full profile.

07

Biomarkers

Elevated levels of methylglyoxal, glyoxal, and other dicarbonylsMeasurement of downstream AGEs (e.g., carboxymethyl-lysine) as surrogate markers

Beyond the preview

Go deeper on AGE precursor molecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AGE precursor molecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call